We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Mobile Spirometer Measures Lung Function Between Physician Visits

By HospiMedica International staff writers
Posted on 16 Jun 2015
A handheld, wireless spirometer enables in-home tracking and monitoring of asthma and chronic obstructive pulmonary disease (COPD). More...


The Cohero Health mobile spirometer assesses critical lung function metrics as precisely as clinical-grade spirometers, including peak flow, forced vital capacity (FVC), and forced expiratory volume (FEV1), thus providing a much more accurate picture of lung health. The mobile spirometer is paired via Bluetooth with a smartphone or tablet, enabling real-time measurement and reporting via the AsthmaHero and BreatheSmart applications. The data can be integrated into clinical workflows, to empower decision making at point of care, or as a long-term patient monitoring tool.

The apps can also deliver customized medication reminders and check medication compliance via proprietary HeroTracker sensors. They can thus track and analyze the effects on lung function of maintenance and rescue medication use, along with external triggers. In conjunction with the mobile spirometer, the integrated, connected healthcare platform can help improve clinical decision making and prevent acute events. The mobile spirometer is a product of Cohero Health (New York, NY, USA).

“We are enhancing respiratory care by recording critical measurements over time, outside of a physician’s office,” said Melissa Manice, PhD, MPH, co-founder and CEO of Cohero Health. “This longitudinal view of changes in lung function over time, in parallel with medication adherence tracking, equips physicians to partner with their patient to make more informed treatment decisions together.”

“The inclusion of a mobile spirometer in our platform allows stakeholders to track, for the first time ever, how patients are using their medication, and how they are responding to their medication, in real time,” added Daniel Weinstein, co-founder and COO of Cohero Health. “Through robust tracking, motivating better behaviors, and early identification of potential acute events, the Cohero Health platform enables better patient management, reduced costs to the healthcare system, and most importantly, healthier patients.”

Related Links:

Cohero Health



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.